Research ArticleClinicopathologic Conferences
Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma
David L. Bushnell, Mark A. Boles, Gary E. Kaufman, Marie A. Wadas and W. Earl Barnes
Journal of Nuclear Medicine December 1992, 33 (12) 2214-2221;
David L. Bushnell
Mark A. Boles
Gary E. Kaufman
Marie A. Wadas
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma
David L. Bushnell, Mark A. Boles, Gary E. Kaufman, Marie A. Wadas, W. Earl Barnes
Journal of Nuclear Medicine Dec 1992, 33 (12) 2214-2221;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
- The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
- Increasing Efficacy and Safety of Treatments of Patients with Well-Differentiated Thyroid Carcinoma by Measuring Body Retentions of 131I
- Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
- Thyroid Carcinoma with High Levels of Function: Treatment with 131I